These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19760037)
1. Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk. Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U Breast Cancer Res Treat; 2010 May; 121(1):185-94. PubMed ID: 19760037 [TBL] [Abstract][Full Text] [Related]
2. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade. Dünnebier T; Bermejo JL; Haas S; Fischer HP; Pierl CB; Justenhoven C; Brauch H; Baisch C; Gilbert M; Harth V; Spickenheuer A; Rabstein S; Pesch B; Brüning T; Ko YD; Hamann U Int J Cancer; 2009 Aug; 125(3):596-602. PubMed ID: 19358266 [TBL] [Abstract][Full Text] [Related]
3. Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population-based GENICA study and external genetic databases. Bermejo JL; Kabisch M; Dünnebier T; Schnaidt S; Melchior F; Fischer HP; Harth V; Rabstein S; Pesch B; Brüning T; Justenhoven C; Brauch H; Baisch C; Ko YD; Hamann U Int J Cancer; 2013 Jul; 133(2):362-72. PubMed ID: 23338788 [TBL] [Abstract][Full Text] [Related]
4. HRM screening of the UBC9 gene encoding the SUMO-E2-conjugating enzyme - case-control study in breast cancer. Bialik P; Wysokinski D; Slomka M; Morawiec Z; Strapagiel D; Wozniak K Exp Oncol; 2020 Jun; 42(2):130-134. PubMed ID: 32602284 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk. Wozniak K; Krupa R; Synowiec E; Morawiec Z Pathol Oncol Res; 2014 Jan; 20(1):67-72. PubMed ID: 23873416 [TBL] [Abstract][Full Text] [Related]
6. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505 [TBL] [Abstract][Full Text] [Related]
7. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer. Mirecka A; Morawiec Z; Wozniak K Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176 [TBL] [Abstract][Full Text] [Related]
8. SUMO pathway components as possible cancer biomarkers. Mattoscio D; Chiocca S Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214 [TBL] [Abstract][Full Text] [Related]
9. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells. Xu J; Watkins T; Reddy A; Reddy ES; Rao VN Int J Oncol; 2009 Apr; 34(4):939-49. PubMed ID: 19287951 [TBL] [Abstract][Full Text] [Related]
10. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation. Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212 [TBL] [Abstract][Full Text] [Related]
11. Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study. Ahn K; Song JH; Kim DK; Park MH; Jo SA; Koh YH Neurosci Lett; 2009 Nov; 465(3):272-5. PubMed ID: 19765634 [TBL] [Abstract][Full Text] [Related]
12. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection. Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of DNA double-strand breaks repair in breast cancer is decreased in carriers of the variant allele of the UBC9 gene c.73G>A polymorphism. Synowiec E; Krupa R; Morawiec Z; Wasylecka M; Dziki L; Morawiec J; Blasiak J; Wozniak K Mutat Res; 2010 Dec; 694(1-2):31-8. PubMed ID: 20863840 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide destabilizes Pias3 and regulates sumoylation. Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106 [TBL] [Abstract][Full Text] [Related]
15. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. Lin JY; Ohshima T; Shimotohno K FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968 [TBL] [Abstract][Full Text] [Related]
16. Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy. Han JY; Lee GK; Yoo SY; Yoon SJ; Cho EY; Kim HT; Lee JS Pharmacogenomics J; 2010 Apr; 10(2):86-93. PubMed ID: 19859084 [TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study. Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512 [TBL] [Abstract][Full Text] [Related]
18. Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis. Moschos SJ; Mo YY J Mol Histol; 2006 Sep; 37(5-7):309-19. PubMed ID: 16758298 [TBL] [Abstract][Full Text] [Related]
19. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO. Yunus AA; Lima CD Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321 [TBL] [Abstract][Full Text] [Related]
20. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population. Kim KY; Han W; Noh DY; Kang D; Kwack K Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]